ACCIÓ awards the Institute’s Innovation Department with the quality seal TECNIO and two VALUNI grants for technology transfer projects
The 8th “Vi per Vida” (“Wine for Life” in English) will be held for 300 participants on Sunday 7 May in Mollerussa and will cost 10 euros per person.
The event aims to raise funds to support research into cancer and metastasis conducted at IRB Barcelona.
This fundraising initiative draws public attention to the importance of scientific research.
Croatian scientist Fran Supek is launching his Genome Data Science (aGENDAS) laboratory.
aGENDAS is starting this April and will promote the research in Big Data, an strategic area also for the Barcelona Institute of Science and Technology (BIST).
With this new group, the Institute now hosts 24 laboratories and seven core facilities.
The announcement took place during the BIST Founding Conference on Friday 31 March at the Centre de Cultura Contemporània de Barcelona.
100 secondary school students aged between 16 and 18 years old will have the chance to experience the Barcelona International Youth Science Challenge (BIYSC) 2017.
It is a two-week (10-21 July) scientific summer camp organised by the Catalunya-La Pedrera Foundation in collaboration with first-class research centres all over Catalonia.
The registration period is now open for BIYSC, in which IRB Barcelona coordinates a project in biomedicine.
The 11th international partnering conference comes to Barcelona from 20 to 22 March.
19 young researchers at IRB Barcelona will also be attending the three-day conference.
BIO-Europe Spring is the premier springtime partnering conference for the biotechnology industry.
IRB Barcelona is to participate in the twelfth edition of the Catalunya La Pedrera Foundation's Teachers and Science Programme.
Teachers will work alongside the scientists to develop resources that can be taken back to the classroom.
IRB Barcelona has received 18 M € funding for 11 projects in the fields of Life Sciences and of Physics and Engineering.
IRB Barcelona starts a project with the long-term goal to achieve an injectable frataxin treatment able to reach the brain.
Frataxin is the protein that is reduced in those affected by this rare and degenerative disease, which has no cure.
The patients’ associations Babel Family and ASOGAF in Granada provide the funding for the initial 18 months of this challenge.
Marc Liesa received his PhD in 2008 after completing his doctoral studies in Antonio Zorzano's Complex Metabolic Diseases and Mitochondria Laboratory.
This award recognises the excellence of former IRB Barcelona scientists.
The jury for the prize acknowledges Marc Liesa’s important contributions to mitochondrial biology.